Exelixis, Inc.

Alameda,  CA 
United States
https://www.cabometyxhcp.com/

• Booth: 3005a

Founded in 1994, Exelixis, Inc. (Nasdaq: EXEL) is a biotechnology company that strives to accelerate the discovery, development and commercialization of new medicines. To ensure you have the latest clinical data, including links to our pivotal trial publications, and important product information, visit our website.

Brands: https://events.jspargo.com/ASCO21/CUSTOM/exelixis.png

 Press Releases

• FULL PRESCRIBING INFORMATION (Mar 19, 2021)
  https://tinyurl.com/y3ouaouf

• EXELIXIS ACCESS SERVICES® (EASE) (Mar 19, 2021)
  https://tinyurl.com/y5z2rfy4 

• CABOMETYX RESOURCES (Mar 19, 2021)
  https://www.cabometyxhcp.com/resources 

• NOW APPROVED ANNOUNCEMENT LETTER (Mar 19, 2021)
  https://www.cabometyxhcp.com/downloads/checkmate-9ER_announcement.pdf

• CABOSUN TRIAL PUBLICATION (Mar 19, 2021)

  https://eorder.sheridan.com/3_0/app/orders/7582/article.php#115

• CELESTIAL TRIAL PUBLICATION (Mar 19, 2021)
  https://www.nejm.org/doi/full/10.1056/NEJMoa1717002

• CheckMate– 9 ER Trial Publication (Mar 30, 2021)
   https://www.nejm.org/doi/full/10.1056/NEJMoa2026982